[Rate of cutaneous drug hypersensitivity].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000700:Analgesics / Q000009:adverse effects / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D003873:Dermatitis, Exfoliative / Q000139:chemically induced; D003875:Drug Eruptions / Q000453:epidemiology*; D004892:Erythema Multiforme / Q000139:chemically induced; D004893:Erythema Nodosum / Q000139:chemically induced; D005260:Female; D005859:Germany, East; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012737:Sex Factors; D014581:Urticaria / Q000453:epidemiology; D014652:Vascular Diseases / Q000139:chemically induced
D000700:Analgesics; D000900:Anti-Bacterial Agents; D006993:Hypnotics and Sedatives
Zur Frage der Häufigkeit von Arzneimittel-Allergodermien.